Literature DB >> 20359479

Mitochondria: Their role in ganglion cell death and survival in primary open angle glaucoma.

Neville N Osborne1.   

Abstract

Retinal ganglion cell axons within the globe are functionally specialised being richly provided with many mitochondria. Mitochondria produce the high energy that is required for nerve conduction in the unmylenated part of the ganglion cell axons and for the maintenance of optimum neuronal function. We proposed that in the initiation of glaucoma (POAG) an alteration in the quality of blood flow dynamics in the optic nerve head results in sustained or intermittent ischemia of a defined nature. This results in normal mitochondrial function being negatively affected and as a consequence retinal ganglion cell function is compromised. Ganglion cells in this state are now susceptible to secondary insults which they would normally tolerate. One secondary insult to ganglion cell mitochondria in such a state might be light entering the eye. Other insults to the ganglion cells might come from substances such as glutamate, prostaglandins and nitric oxide released from astrocytes and microglia in the optic nerve head region. Such cascades of events initiated by ischemia to the optic nerve head region ultimately cause ganglion cells to die at different rates. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20359479     DOI: 10.1016/j.exer.2010.03.008

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  64 in total

1.  Light effects on mitochondrial photosensitizers in relation to retinal degeneration.

Authors:  N N Osborne; T A Kamalden; A S A Majid; S del Olmo-Aguado; A G Manso; D Ji
Journal:  Neurochem Res       Date:  2010-10-07       Impact factor: 3.996

Review 2.  Intrinsic axonal degeneration pathways are critical for glaucomatous damage.

Authors:  Gareth R Howell; Ileana Soto; Richard T Libby; Simon W M John
Journal:  Exp Neurol       Date:  2012-01-18       Impact factor: 5.330

Review 3.  Mitochondrial disorders and the eye.

Authors:  Samantha A Schrier; Marni J Falk
Journal:  Curr Opin Ophthalmol       Date:  2011-09       Impact factor: 3.761

Review 4.  Critical pathogenic events underlying progression of neurodegeneration in glaucoma.

Authors:  David J Calkins
Journal:  Prog Retin Eye Res       Date:  2012-08-01       Impact factor: 21.198

Review 5.  Pharmacotherapy of glaucoma.

Authors:  Doreen Schmidl; Leopold Schmetterer; Gerhard Garhöfer; Alina Popa-Cherecheanu
Journal:  J Ocul Pharmacol Ther       Date:  2015-01-14       Impact factor: 2.671

6.  Microvasculature of the Optic Nerve Head and Peripapillary Region in Patients With Primary Open-Angle Glaucoma.

Authors:  Rafaella Nascimento E Silva; Carolina A Chiou; Mengyu Wang; Haobing Wang; Marissa K Shoji; Jonathan C Chou; Erica E D'Souza; Scott H Greenstein; Stacey C Brauner; Milton R Alves; Louis R Pasquale; Lucy Q Shen
Journal:  J Glaucoma       Date:  2019-04       Impact factor: 2.503

7.  Mitochondrial Dynamics in Retinal Ganglion Cell Axon Regeneration and Growth Cone Guidance.

Authors:  Kira L Lathrop; Michael B Steketee
Journal:  J Ocul Biol       Date:  2013-09-21

Review 8.  Mitochondrial disorders and the eye.

Authors:  Nicole J Van Bergen; Rahul Chakrabarti; Evelyn C O'Neill; Jonathan G Crowston; Ian A Trounce
Journal:  Eye Brain       Date:  2011-09-26

Review 9.  Pathophysiology of primary open-angle glaucoma from a neuroinflammatory and neurotoxicity perspective: a review of the literature.

Authors:  Karine Evangelho; Maria Mogilevskaya; Monica Losada-Barragan; Jeinny Karina Vargas-Sanchez
Journal:  Int Ophthalmol       Date:  2017-12-30       Impact factor: 2.031

10.  The brain and eye: Treating cerebral and retinal ischemia through mitochondrial transfer.

Authors:  Matt Heyck; Brooke Bonsack; Henry Zhang; Nadia Sadanandan; Blaise Cozene; Chase Kingsbury; Jea-Young Lee; Cesar V Borlongan
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.